ISIN | LU0329630999 |
---|---|
Valor Number | 3535010 |
Bloomberg Global ID | VARMVP1 LX |
Fund Name | Variopartner SICAV - MIV Global Medtech Fund P1 |
Fund Provider |
MIV Global Medtech Fund
Feldeggstrasse 55 8008 Zürich Schweiz Phone: +41 44 253 64 11 E-Mail: info@mivam.ch |
Fund Provider | MIV Global Medtech Fund |
Representative in Switzerland |
Vontobel Fonds Services AG Zürich Phone: +41 58 283 74 77 |
Distributor(s) |
Vontobel Fonds Services AG Zürich Phone: +41 58 283 74 77 |
Asset Class | Equities |
EFC Category | Equity Health Care |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | This Sub-Fund aims to achieve maximum capital growth by means of investments in the sector of medical technology worldwide. In order to achieve this, and taking account of the principle of risk diversification, a minimum of two-thirds of the SubFund’s total assets are invested directly in equities, equity-like transferable securities, participation certificates, depositary receipts, such as American Depositary Receipts (ADRs), Global Depositary Receipts (GDRs) and European Depositary Receipts (EDRs) referring to such securities, etc. from issuers worldwide, mainly active in the sector of medical technology. Besides this, up to one third of the total assets of the Sub-Fund may be invested in participation securities from companies that are not or not principally active in the sector of medical technology. |
Peculiarities |
Current Price * | 2,466.21 CHF | 19.11.2024 |
---|---|---|
Previous Price * | 2,481.82 CHF | 18.11.2024 |
52 Week High * | 2,503.20 CHF | 27.03.2024 |
52 Week Low * | 2,060.33 CHF | 28.11.2023 |
NAV * | 2,466.21 CHF | 19.11.2024 |
Issue Price * | 2,466.21 CHF | 19.11.2024 |
Redemption Price * | 2,466.21 CHF | 19.11.2024 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 1,904,354,230 | |
Unit/Share Assets *** | 243,243,323 | |
Trading Information SIX |
YTD Performance | +15.62% |
29.12.2023 - 19.11.2024
29.12.2023 19.11.2024 |
---|---|---|
1 month | +0.74% |
21.10.2024 - 19.11.2024
21.10.2024 19.11.2024 |
3 months | +4.54% |
19.08.2024 - 19.11.2024
19.08.2024 19.11.2024 |
6 months | +1.03% |
21.05.2024 - 19.11.2024
21.05.2024 19.11.2024 |
1 year | +20.11% |
20.11.2023 - 19.11.2024
20.11.2023 19.11.2024 |
2 years | +13.79% |
21.11.2022 - 19.11.2024
21.11.2022 19.11.2024 |
3 years | -15.06% |
19.11.2021 - 19.11.2024
19.11.2021 19.11.2024 |
5 years | +10.42% |
19.11.2019 - 19.11.2024
19.11.2019 19.11.2024 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | 0.1183 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date | 19.11.2024 |
Abbott Laboratories | 9.94% | |
---|---|---|
Boston Scientific Corp | 9.92% | |
Intuitive Surgical Inc | 9.91% | |
Stryker Corp | 9.80% | |
Medtronic PLC | 4.96% | |
Alcon Inc | 4.37% | |
Essilorluxottica | 4.24% | |
Becton Dickinson & Co | 4.11% | |
Hoya Corp | 3.95% | |
Edwards Lifesciences Corp | 3.67% | |
Last data update | 31.10.2024 |
TER | 1.57% |
---|---|
TER date | 28.06.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.50% |
Ongoing Charges *** | 1.56% |
SRRI ***
|
|
SRRI date *** | 31.10.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |